Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, a group of drugs that includes Actos and Avandia, had a two to three times higher risk of macular edema. The risk was higher if patients used insulin in combination with the drugs.

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.